| |
| |
|
| Insider
Information: |
Hbm Bioventures Cayman Ltd |
| Relationship: |
10% Owner |
| City: |
Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
28,058,903 |
|
|
Indirect Shares
|
1,435,154 |
|
|
| Direct
Value |
$286,638,756 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,494,057 |
|
|
| Total
Value |
$286,638,756 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Icagen Inc |
ICGN |
10% Owner |
2005-02-08 |
1,200,000 |
2005-02-08 |
0 |
Premium* |
|
|
Harbor Brewing Company Inc |
HBWOD |
10% Owner |
2005-03-16 |
3,964,615 |
2005-03-16 |
1,435,154 |
Premium* |
|
|
Micrus Endovascular Corp |
MEND |
10% Owner |
2010-02-24 |
1,681,599 |
2005-06-21 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
10% Owner |
2013-03-25 |
2,233,993 |
|
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
10% Owner |
2013-12-17 |
2,441,504 |
2013-06-25 |
0 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
10% Owner |
2014-05-13 |
3,139,902 |
2013-09-30 |
0 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2014-09-26 |
2,780,836 |
|
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2015-05-29 |
1,747,680 |
|
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
10% Owner |
2017-09-14 |
2,334,128 |
|
0 |
Premium* |
|
|
Werewolf Therapeutics, Inc. |
HOWL |
10% Owner |
2021-05-04 |
625,995 |
2021-05-04 |
0 |
Premium* |
|
|
Io Biotech, Inc. |
IOBT |
10% Owner |
2021-11-09 |
2,690,545 |
2021-11-09 |
0 |
Premium* |
|
|
Mineralys Therapeutics, Inc. |
MLYS |
10% Owner |
2023-02-14 |
3,218,106 |
2023-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBWOD |
Harbor Brewing Company In... |
10% Owner |
– – • |
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,435,154 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2011-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,980 |
|
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2014-09-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,780,836 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2014-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,768,260 |
|
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
275,988 |
|
- |
|
| ICGN |
Icagen Inc |
10% Owner |
– – • |
2005-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,200,000 |
1,200,000 |
|
- |
|
| MEND |
Micrus Endovascular Corp |
10% Owner |
– – • |
2005-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,728,083 |
1,728,083 |
|
- |
|
| MEND |
Micrus Endovascular Corp |
10% Owner |
– – • |
2005-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
199,478 |
1,927,561 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2011-02-08 |
4 |
A |
$0.00 |
$13,725,237 |
D/D |
2,508,903 |
2,601,883 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
10% Owner |
– – • |
2013-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,841,495 |
1,841,495 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
10% Owner |
– – • |
2013-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,411,901 |
3,411,902 |
0 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
10% Owner |
– – • |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
625,995 |
625,995 |
0 |
- |
|
| IOBT |
Io Biotech, Inc. |
10% Owner |
– – • |
2021-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,365,545 |
2,365,545 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
10% Owner |
– – • |
2023-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,905,606 |
2,905,606 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2011-11-21 |
4 |
B |
$6.50 |
$1,999,998 |
D/D |
307,692 |
3,445,289 |
2.45 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2011-02-08 |
4 |
B |
$7.00 |
$3,749,998 |
D/D |
535,714 |
3,137,597 |
2.45 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-09-14 |
4 |
S |
$8.52 |
$29,224 |
D/D |
(3,429) |
2,334,128 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-09-13 |
4 |
S |
$8.54 |
$193,956 |
D/D |
(22,721) |
2,337,557 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-09-12 |
4 |
S |
$8.63 |
$90,236 |
D/D |
(10,458) |
2,360,278 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-08-31 |
4 |
S |
$9.50 |
$6,071 |
D/D |
(639) |
2,370,735 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-07-19 |
4 |
S |
$10.50 |
$218,253 |
D/D |
(20,786) |
2,421,367 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-07-20 |
4 |
S |
$10.50 |
$246,173 |
D/D |
(23,445) |
2,397,922 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-07-24 |
4 |
S |
$10.50 |
$1,680 |
D/D |
(160) |
2,397,762 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-08-07 |
4 |
S |
$10.50 |
$186,795 |
D/D |
(17,790) |
2,373,387 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-08-08 |
4 |
S |
$10.50 |
$21,137 |
D/D |
(2,013) |
2,371,374 |
0 |
- |
|
104 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
